In CRC, the genetic changes are mostly mutations in p53 [50], KRAS, NRAS or BRAF, where KRAS mutations are associated with a poor prognosis in particular because they go along with persistent or recurring liver metastases [51]. Here, TP53 is linked to colorectal carcinoma.